Search Results

2 results

  1. CORESTA Congress, Edinburgh, 2010, SSPTPOST 19

    Bronchial epithelial cell (NCI-H292) response to cigarette smoke total particulate matter (TPM): Development and utilisation of a simple cell culture model of chronic obstructive pulmonary disease (COPD)

    FOSS-SMITH G.; HEWITT K.; HASWELL L.E.; CORKE S.; GARCIA-CANTON C.; PHILLIPS G.J.
    British American Tobacco, Group R&D, Southampton, UK
    COPD is a complex and multifaceted condition that can be caused by cigarette smoking. In smokers, chronic exposure can lead to the development of COPD specific pathologies such as emphysema, small airway disease and mucus hyper-secretion. On a cellular ...
  2. CORESTA Meeting, Smoke Science/Product Technology, Jeju, 2007, SSPTPOST 12

    ISO 17025 accreditation for in vitro toxicology tests on cigarette smoke products

    COOKE L.; COWIN R.; LANGFORD R.; DELVES S.; GARCIA-CANTON C.; JONES S.; BLACK S.
    Advanced Technologies Ltd., Cambridge, UK
    One of the British American Tobacco Group of companies, Advanced Technologies (Cambridge) Ltd (ATC), performs 'duty of care' in vitro toxicology testing on tobacco products, to examine the potential harmful effects of cigarette smoke on DNA. ...